Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00580606
Show Display Options
Rank Status Study
1 Completed
Has Results
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Conditions: Food Hypersensitivity;   Hypersensitivity;   Immediate Hypersensitivity;   Peanut Hypersensitivity
Interventions: Drug: Glycerinated peanut allergenic extract;   Drug: Placebo for peanut extract (glycerin)

Study has passed its completion date and status has not been verified in more than two years.